Stay updated on Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.

Latest updates to the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedThis reflects a minor ClinicalTrials.gov site software/version update shown in the page footer, with the study content remaining the same.SummaryDifference0.0%

- Check11 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedThe site now displays revision v3.5.0; revision v3.4.3 has been removed.SummaryDifference0.0%

- Check47 days agoChange Detected- Revision: v3.4.3 added; previous v3.4.2 removed. This update affects only the page's version label and does not alter study content or functionality.SummaryDifference0.0%

- Check76 days agoChange DetectedAdministrative updates: Revision: v3.4.2 is added and older notices (v3.4.1) are removed; these changes do not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedAdded a site-wide funding status notice directing users to cc.nih.gov and opm.gov, and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.